Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Kidoz (KDOZF) Research & Development (2016 - 2025)

Kidoz has reported Research & Development over the past 10 years, most recently at $1.2 million for Q4 2025.

  • Quarterly results put Research & Development at $1.2 million for Q4 2025, up 14.09% from a year ago — trailing twelve months through Dec 2025 was $4.5 million (up 25.7% YoY), and the annual figure for FY2025 was $4.6 million, up 32.34%.
  • Research & Development reached $1.2 million in Q4 2025 per KDOZF's latest filing, down from $1.2 million in the prior quarter.
  • Across five years, Research & Development topped out at $1.2 million in Q3 2025 and bottomed at $337293.0 in Q1 2021.
  • Median Research & Development over the past 5 years was $749865.0 (2023), compared with a mean of $762646.6.
  • The largest annual shift saw Research & Development soared 75.95% in 2022 before it dropped 4.33% in 2025.
  • Over 5 years, Research & Development stood at $497950.0 in 2021, then soared by 45.19% to $722988.0 in 2022, then increased by 7.79% to $779273.0 in 2023, then soared by 36.14% to $1.1 million in 2024, then grew by 14.09% to $1.2 million in 2025.
  • Business Quant data shows Research & Development for KDOZF at $1.2 million in Q4 2025, $1.2 million in Q3 2025, and $1.2 million in Q2 2025.